suven: PE Advent completes acquisition of Suven Pharma, appoints new Board and management team

Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired a 50.1% stake in Suven in December 2020 for INR 6,313 crore ($866 million) and will launch an open offer for an additional 26% of the company.

Related Keywords

India ,Kozhikode ,Kerala ,Hyderabad ,Andhra Pradesh ,Jj Asia Pacific ,Venkat Jasti ,Suven Pharma ,Suven Lifesciences ,Pankaj Patwari ,Matangi Gowrishankar ,Vinod Rao ,Venkateswarlu Jasti ,Annaswamy Vaidheesh ,Shweta Jalan ,Sudhir Kumar Singh ,Stefan Stoffel ,James Mullen ,Abhijit Mukherjee ,Prasada Raju ,V Prasada Raju ,Offering College ,Aragen Life Sciences ,Advent International On ,Cohance Life Sciences ,Indian School Of Business ,Healthcare Management Analytics Programme ,Capability Development ,Advisory Council ,Granules India Ltd ,Advent International ,Healthcare Expertise ,Granules India ,Investor Relations ,Suven ,Vaidheesh ,Pnb ,